Cellular hierarchy framework based on single-cell and bulk RNA sequencing reveals fatty acid metabolic biomarker MYDGF as a therapeutic target for ccRCC
BackgroundFatty acid metabolism (FAM) reprogramming is a prominent feature of clear cell renal cell carcinoma (ccRCC). Nevertheless, the effect of FAM reprogramming on the heterogeneity and prognosis of ccRCC individuals remains insufficiently understood.MethodsWe utilized single-cell sequencing and...
Saved in:
| Main Authors: | Ning Wang, Ziyu Xu, Lina Zhang, Yanfang Lu, Yanliang Wang, Lei Yan, Huixia Cao, Limeng Wang, Fengmin Shao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1615601/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
LPCAT3 regulates the immune infiltration and prognosis of ccRCC patients by mediating ferroptosis and endoplasmic reticulum stress
by: Bei Feng, et al.
Published: (2025-04-01) -
ARHGAP9 may be used as a novel prognostic biomarker associated with tumor immunity and cellular composition in ccRCC
by: Yini Wang, et al.
Published: (2025-05-01) -
CRISPR/Cas9-based discovery of ccRCC therapeutic opportunities through molecular mechanism and immune microenvironment analysis
by: Bo Han, et al.
Published: (2025-07-01) -
CircABCA1 promotes ccRCC by reprogramming cholesterol metabolism and facilitating M2 macrophage polarization through IGF2BP3-mediated stabilization of SCARB1 mRNA
by: Hao Ning, et al.
Published: (2025-07-01) -
Prognostic implications of ERLncRNAs in ccRCC: a novel risk score model and its association with tumor mutation burden and immune microenvironment
by: Kunlun Feng, et al.
Published: (2025-02-01)